The POST-ACS Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

Also called NCT05322200

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Swansea Bay University Health Board (from the registry)
Registry
  • NCT NCT05322200
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05322200. Randomized; triple masking; primary purpose treatment. Start 2022-08-31 (actual); primary completion 2024-04-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The POST-ACS Study
Condition
Diabetes Mellitus
Condition
Acute Coronary Syndrome
Intervention (Radiation)
A computerized tomography (CT) coronary angiogram
Intervention (Procedure)
Vicorder (Skidmore medical, UK)
Intervention (Other)
Blood tests for inflammation and oxidative stress markers
Lead sponsor
Swansea Bay University Health Board (class: other)

Record details

Record id
cardio:ct-nct05322200
Content hash
595094a2ec7bb05090f100494015ddb39bb4198fe6e4c86c6c736d7afd2b0ecd